TEX46 (Gene)

Organism:

Homo sapiens

Taxonomy (Entity type)

Gene:

TARGET ID 08805

Collection (Entity type)

Synonyms:C1orf234, ENTREZ:729059, HGNC:44651, NM_001242521, NP_001229450, TEX#, TEX46, testis expressed 46

Id:ENSG00000227868

Entrez:729059

Ensembl:ENSG00000227868

Description:testis expressed 46

Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TEX46's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TEX46.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TEX46.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TEX46.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TEX46.

Results found

Linked to

	Label	Description
	GSE252944 AKT inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 3 V 5 GEMCITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 11 V 3 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE245270 2 V 4 ISOPROTERENOL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 11 V 5 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE131649 6 V 10 HEMIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE148200 3 V 5 GEMCITABINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 11 V 3 TEMOZOLOMIDE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE245270 2 V 4 ISOPROTERENOL HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 11 V 5 TEMOZOLOMIDE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE131649 6 V 10 HEMIN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.